NL6811829A - - Google Patents

Info

Publication number
NL6811829A
NL6811829A NL6811829A NL6811829A NL6811829A NL 6811829 A NL6811829 A NL 6811829A NL 6811829 A NL6811829 A NL 6811829A NL 6811829 A NL6811829 A NL 6811829A NL 6811829 A NL6811829 A NL 6811829A
Authority
NL
Netherlands
Application number
NL6811829A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6811829A publication Critical patent/NL6811829A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL6811829A 1967-08-21 1968-08-20 NL6811829A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38494/67A GB1241657A (en) 1967-08-21 1967-08-21 Improvements in or relating to cephalosporin compounds

Publications (1)

Publication Number Publication Date
NL6811829A true NL6811829A (cg-RX-API-DMAC7.html) 1969-02-25

Family

ID=10403834

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6811829A NL6811829A (cg-RX-API-DMAC7.html) 1967-08-21 1968-08-20

Country Status (10)

Country Link
US (1) US3658799A (cg-RX-API-DMAC7.html)
JP (2) JPS5010872B1 (cg-RX-API-DMAC7.html)
AT (2) AT306233B (cg-RX-API-DMAC7.html)
BE (1) BE719711A (cg-RX-API-DMAC7.html)
CA (1) CA927381A (cg-RX-API-DMAC7.html)
CH (2) CH561726A5 (cg-RX-API-DMAC7.html)
DE (2) DE1795184A1 (cg-RX-API-DMAC7.html)
FR (1) FR1589109A (cg-RX-API-DMAC7.html)
GB (1) GB1241657A (cg-RX-API-DMAC7.html)
NL (1) NL6811829A (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5248996B1 (cg-RX-API-DMAC7.html) * 1971-01-29 1977-12-14 Glaxo Lab Ltd
JPS531280B1 (cg-RX-API-DMAC7.html) * 1971-05-14 1978-01-17

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755256A (cg-RX-API-DMAC7.html) * 1969-08-26 1971-02-25 Glaxo Lab Ltd
US3922268A (en) * 1969-12-08 1975-11-25 Lilly Co Eli 3-Halomethyl-{66 {hu 3-Cephalosporin esters
GB1360860A (en) * 1970-07-08 1974-07-24 Ciba Geigy Ag Cepham compounds process for their manufacture and compositions containing them
GB1426072A (en) * 1973-01-18 1976-02-25 Beecham Group Ltd Cephalosporins
GB1459212A (en) * 1973-08-01 1976-12-22 Glaxo Lab Ltd N-deacylation of 7-acylamido-3-hydroxy-methyl cephalosporins
AR207327A1 (es) * 1974-02-06 1976-09-30 Lilly Co Eli Un procedimiento para preparar acidos 3-cefem 3-sulfonatos y sus esteres
US3890311A (en) * 1974-03-18 1975-06-17 American Home Prod 7-(2-(1-(phenylsulfonyl)-2-pyrrolidinylthio)acetamino)cephalosporanic acids
DK159154C (da) * 1975-02-24 1991-02-11 Takeda Chemical Industries Ltd Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
US4048160A (en) * 1976-03-22 1977-09-13 Eli Lilly And Company Process for preparation of 7-alkoxy-3-bromomethylcephems
US4042585A (en) * 1976-03-22 1977-08-16 Eli Lilly And Company Process for preparation of 3-halomethylcephems
US4048163A (en) * 1976-03-22 1977-09-13 Eli Lilly And Company Process for preparation of 7-alkoxy-3-chloromethylcephems
US4144391A (en) * 1977-03-07 1979-03-13 Eli Lilly And Company Cephalosporin displacement reaction
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4266049A (en) * 1980-02-20 1981-05-05 Eli Lilly And Company Process for 3-iodomethyl cephalosporins
NL8005041A (nl) * 1980-09-05 1982-04-01 Gist Brocades Nv Werkwijze voor de bereiding van thioethers, alsmede gesilyleerde thiolen voor toepassing bij deze werkwijze.
EP0262744B1 (en) * 1986-10-02 1994-03-23 Asahi Kasei Kogyo Kabushiki Kaisha A process for preparing 3-alkoxymethylcephalosphorins
JP2612493B2 (ja) * 1988-05-24 1997-05-21 旭化成工業株式会社 3―置換メチル―3―セフェム―4―カルボン酸類の製造方法
US5302713A (en) * 1992-03-31 1994-04-12 Industrial Technology Research Institute Method for the preparation of Δ3 -7-substituted amino desacetoxy cephalosporanic acid
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
AT401177B (de) 1993-10-22 1996-07-25 Biochemie Gmbh Verfahren zur herstellung von 7-amino-3-cephem-4-carbonsäure-derivaten
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
CA2206804C (en) * 1994-12-13 2002-03-19 Euro-Celtique, S.A. Trisubstituted thioxanthines
DE69531506T2 (de) * 1994-12-13 2004-06-24 Euroceltique S.A. Arylthioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US7423168B2 (en) * 2002-08-29 2008-09-09 Mitsubishi Chemical Corporation Method for producing allyl compound
EP3426663B1 (en) 2016-03-07 2020-01-29 Dhanuka Laboratories Ltd. A process for alkylating the hydroxymethyl group at position -3 of cephalosporins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5248996B1 (cg-RX-API-DMAC7.html) * 1971-01-29 1977-12-14 Glaxo Lab Ltd
JPS531280B1 (cg-RX-API-DMAC7.html) * 1971-05-14 1978-01-17

Also Published As

Publication number Publication date
CA927381A (en) 1973-05-29
US3658799A (en) 1972-04-25
BE719711A (cg-RX-API-DMAC7.html) 1969-02-20
AT303955B (de) 1972-12-27
CH561222A5 (cg-RX-API-DMAC7.html) 1975-04-30
FR1589109A (cg-RX-API-DMAC7.html) 1970-03-23
DE1795643A1 (de) 1972-11-09
CH561726A5 (cg-RX-API-DMAC7.html) 1975-05-15
AT306233B (de) 1973-03-26
GB1241657A (en) 1971-08-04
JPS5127679B1 (cg-RX-API-DMAC7.html) 1976-08-13
DE1795184A1 (de) 1972-03-16
JPS5010872B1 (cg-RX-API-DMAC7.html) 1975-04-24

Similar Documents

Publication Publication Date Title
AU5765369A (cg-RX-API-DMAC7.html)
JPS5127679B1 (cg-RX-API-DMAC7.html)
AU416737B2 (cg-RX-API-DMAC7.html)
AU342066A (cg-RX-API-DMAC7.html)
AU2277767A (cg-RX-API-DMAC7.html)
AU610966A (cg-RX-API-DMAC7.html)
AU2116667A (cg-RX-API-DMAC7.html)
AU1273466A (cg-RX-API-DMAC7.html)
AU2256867A (cg-RX-API-DMAC7.html)
AU3189468A (cg-RX-API-DMAC7.html)
AU2454867A (cg-RX-API-DMAC7.html)
AU3151267A (cg-RX-API-DMAC7.html)
AU2528767A (cg-RX-API-DMAC7.html)
AU2977667A (cg-RX-API-DMAC7.html)
AU97666A (cg-RX-API-DMAC7.html)
BE609934A (cg-RX-API-DMAC7.html)
AU2406369A (cg-RX-API-DMAC7.html)
AU23366A (cg-RX-API-DMAC7.html)
AU34866A (cg-RX-API-DMAC7.html)
AU408412B2 (cg-RX-API-DMAC7.html)
BE692493A (cg-RX-API-DMAC7.html)
AU459699A (cg-RX-API-DMAC7.html)
AU1868267A (cg-RX-API-DMAC7.html)
AU1677166A (cg-RX-API-DMAC7.html)
BE692409A (cg-RX-API-DMAC7.html)